Search
chlorpheniramine/hydrocodone (Tussionex)
Indications: cough suppression
Contraindications:
1) patients < 6 years of age (due to susceptibility to life-threatening & fatal respiratory depression)
Dosage: every 12 hours as directed
Pharmacokinetics: long-acting
Adverse effects:
- respiratory depression
Mechanism of action:
- ;ong-acting hydrocodone-containing cough product
Interactions
drug adverse effects of antitussive agent(s)
General
antitussive agent
pharmacologic combination
References
FDA MedWatch
http://www.fda.gov/medwatch/safety/2008/safety08.htm#Tussionex
Components
chlorpheniramine (Chlor-Trimeton)
hydrocodone; dihydrocodeinone (Zohydro ER, Hysingla ER)